Bayer Aktiengesellschaft (ETR:BAYN)
Germany
· Delayed Price · Currency is EUR | Market Cap | 46.17B |
| Revenue (ttm) | 45.24B |
| Net Income (ttm) | -2.16B |
| Shares Out | 982.42M |
| EPS (ttm) | -2.19 |
| PE Ratio | n/a |
| Forward PE | 14.87 |
| Dividend | 0.11 (0.23%) |
| Ex-Dividend Date | Apr 27, 2026 |
| Volume | n/a |
| Average Volume | 3,920,316 |
| Open | 46.50 |
| Previous Close | 47.00 |
| Day's Range | 46.06 - 47.60 |
| 52-Week Range | 24.81 - 49.78 |
| Beta | 0.85 |
| RSI | 81.89 |
| Earnings Date | Aug 4, 2026 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge... [Read more]
Financial Performance
In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for BAYN stock is "Buy." The 12-month stock price target is €49.50, which is an increase of 5.32% from the latest price.
News
Bayer (BAYRY) Wins Supreme Court Ruling, Boosting Business Prospects
Bayer (BAYRY) Wins Supreme Court Ruling, Boosting Business Prospects
Bayer Gets New Life After Supreme Court's Roundup Ruling
A high-court victory gives the German company more leverage to settle outstanding cases.
‘The decision is sickening’: MAHA leaders feel betrayed by Supreme Court ruling on Roundup weed killer
The Trump administration backed Bayer, the maker of Roundup, angering prominent voices in the “Make America Healthy Again” movement.
Supreme Court hands Bayer a shield against 200,000 Roundup cancer suits
John Durnell spent 20 years hosing down his St. Louis neighborhood with Roundup. He got cancer, won $1.25M — and now the courthouse door is closed.
Supreme Court Rules For Monsanto In Roundup Cancer Warning Case
WASHINGTON (dpa-AFX) - The U.S. Supreme Court has made a significant 7-2 ruling in favor of Monsanto, marking a big win for both the company and its parent, Bayer, in the ongoing legal battles ove...
Bayer Wins Supreme Court Ruling on Glyphosate Risk Claims
Bayer Wins Supreme Court Ruling on Glyphosate Risk Claims
Bayer AG: Monsanto wins landmark Roundup case at U.S. Supreme Court
Ruling should help significantly contain litigation by preempting conflicting state-law- based warning claims Decision provides regulatory clarity for crop input producers, American farmers and co...
Bayer (BAYRY) Secures Legal Win, Shares Surge Following Supreme Court Ruling
Bayer (BAYRY) Secures Legal Win, Shares Surge Following Supreme Court Ruling
Bayer says Durnell Roundup ruling ‘should help significantly contain litigation’
Bayer (BAYRY) stated: “The U.S. Supreme Court issued a 7:2 landmark ruling in the Durnell Roundup case on Thursday, affirming that the Federal Insecticide, Fungicide, and Rodenticide Act expressly pre...
Bayer's stock jumps after Supreme Court sides with Roundup weedkiller manufacturer
The court ruled that states cannot have differing labeling warning rules than federal law requires.
Bayer Surges After Winning Its Supreme Court Roundup Challenge
Bayer stock rocketed to a four-month high Thursday after the U.S. Supreme Court blocked thousands of lawsuits tied to Roundup.
Bayer wins Supreme Court case making it harder to sue over glyphosate in Monsanto's Roundup
The Supreme Court in a 7-2 decision on Thursday said Bayer cannot be sued over state-level claims that the company failed to warn of cancer risks from its weedkiller Roundup and its chemical glyphosat...
Supreme Court sides with Bayer bid to limit Roundup weedkiller lawsuits
CNBC's Eamon Javers reports on the Supreme Court's ruling in the lawsuit involving Bayer, the maker of Roundup weedkiller.
Bayer AG: US Supreme Court rules in favor of Monsanto in the Durnell case
The U.S. Supreme Court decision is good for science, farmers, and industries that depend on regulatory clarity for innovation. It should help significantly contain the Roundup litigation after nea...
Bayer Not Liable After Man Claimed Weedkiller Caused His Cancer, Supreme Court Rules
The Supreme Court ruled in favor of former agrochemical giant Monsanto on Thursday in a dispute over whether the company should have warned consumers about potential harms arising from its weed killer...
Bayer shares surge after U.S. Supreme Court rules in favour of company
Shares in Germany's Bayer surged by the most in 23 years on Thursday after the U.S. Supreme Court sided with the the company concerning lawsuits related its Roundup weedkiller.
Bayer confirms Supreme Court rules in favor of Monsanto in Durnell case
Bayer (BAYRY) issued the following statement: “The U.S. Supreme Court decision is good for science, farmers, and industries that depend on regulatory clarity for innovation. It should help significant...
Bayer Wins Supreme Court Challenge Over Roundup Litigation
The decision will help the company in its bid to resolve thousands of claims that the popular weedkiller caused cancer.
Supreme Court scales back Roundup cancer lawsuits
The U.S. Supreme Court reined in thousands of lawsuits pursued in state courts accusing Bayer of failing to warn users that the active ingredient in its Roundup weedkiller causes cancer, handing a maj...
Bayer's $7.25 billion Roundup deal faces possible speed bump in state court
A Missouri state court judge may postpone an upcoming hearing on Bayer's proposed $7.25 billion settlement of lawsuits alleging that the company's Roundup weedkiller causes cancer, potentially slowing...
Bayer, Iambic collaborate for AI drug discovery
Bayer (BAYRY) and Iambic Therapeutics announced a drug discovery collaboration in which Bayer will discover new medicines using Iambic’s AI-driven platform. The collaboration is focused on small molec...
Bayer and Iambic Collaborate to Advance Drug Discovery with AI
BERLIN & SAN DIEGO--(BUSINESS WIRE)--Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a...
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada
CALGARY, Alberta--(BUSINESS WIRE)--The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this ro...
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada
The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this role, she will lead 550+ employees wo...
EQS-PVR: Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Bayer Aktiengesellschaft Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Euro...